VEGFR-3 Binding pepetides and their use for inhibiting angiogenesis
Details for Australian Patent Application No. 2008200559 (hide)
International Classifications
Event Publications
21 February 2008 Complete Application Filed
28 February 2008 Application Open to Public Inspection
Published as AU-A-2008200559
6 March 2008 Corrigenda
Applications OPI - Name Index Under the name Ludwig Institute for Cancer Research; Licentia Ltd, Application No. 2008200559, under INID (54) correct the title to read VEGFR-3 Binding peptides and their use for inhibiting angiogenesis. Specifications Republished The following specifications contained errors when advertised OPI, Accepted or Certified. They have been reissued on the AU-A or AU-B CD-ROM of this Journal date. 2002301388 Domani Eyewear Pty Ltd 2006220390 Accenture Global Services GmbH
1 May 2008 Assignment before Grant
Ludwig Institute for Cancer Research; Licentia Ltd. The application has been assigned to Vegenics Limited
12 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2008200560-Financial institution-based transaction processing system and approach
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser